Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. It is characterized by malignant T-cell lymphocytes in the skin. It presents as patch, plaque, or tumor stage and is often ...

Understanding the Context

Please provide your email address to receive an email when new articles are posted on . Topical synthetic hypericin ointment, activated with visible light, shows efficacy in reducing mycosis fungoides ... Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...

Key Insights

News Medical: Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas? Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas? Business Wire: Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides Mycosis fungoides is a rare type of cutaneous T-cell lymphoma. It develops when T cells mutate into cancer cells. The exact trigger for these mutations remains unclear, but it may involve bacterial ...

Final Thoughts

Everyday Health: What Are Mycosis Fungoides and Sézary Syndrome? Symptoms, Causes, Diagnosis, Treatment, and Prevention Both mycosis fungoides and Sézary syndrome fall under the umbrella of cutaneous T-cell lymphomas (CTCL), a category of non-Hodgkin lymphomas that greatly impact the skin (cutaneous refers to the skin) ... What Are Mycosis Fungoides and Sézary Syndrome? Symptoms, Causes, Diagnosis, Treatment, and Prevention LIVERPOOL - A 1-day multidisciplinary 'super clinic' set up to treat patients with a diagnosis of mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) was featured as a possible model for future care ... Mycosis fungoides, an uncommon cutaneous T cell lymphoma, which produces plaques which are the result of the accumulation of the malignant T cells in the upper dermis. The link between head and neck ...

Nasdaq: Innate : Data From Phase 2 Trial Of Lacutamab In Advanced Mycosis Fungoides Shows Clinical Activity (RTTNews) - Innate Pharma SA (IPHA) said that lacutamab, an anti-KIR3DL2 antibody, demonstrated clinical responses in patients with mycosis fungoides (MF), in the ongoing Phase 2 TELLOMAK clinical ... Innate : Data From Phase 2 Trial Of Lacutamab In Advanced Mycosis Fungoides Shows Clinical Activity